The University of Southampton
University of Southampton Institutional Repository

In vivo retargeting of adenovirus type 5 to ?v?6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery

Record type: Article

A key impediment to successful cancer therapy with adenoviral vectors is the inefficient transduction of malignant tissue in vivo. Compounding this problem is the lack of cancer-specific targets, coupled with a shortage of corresponding high-efficiency ligands, permitting selective retargeting. The epithelial cell-specific integrin ?v?6 represents an attractive target for directed therapy since it is generally not expressed on normal epithelium but is upregulated in numerous carcinomas, where it plays a role in tumor progression. We previously have characterized a high-affinity, ?v?6-selective peptide (A20FMDV2) derived from VP1 of foot-and-mouth disease virus. We generated recombinant adenovirus type 5 (Ad5) fiber knob, incorporating A20FMDV2 in the HI loop, for which we validated the selectivity of binding and functional inhibition of ?v?6. The corresponding ?v?6-retargeted virus Ad5-EGFPA20 exhibited up to 50-fold increases in coxsackievirus- and-adenovirus-receptor-independent transduction and up to 480-fold-increased cytotoxicity on a panel of ?v?6-positive human carcinoma lines compared with Ad5-EGFPWT. Using an ?v?6-positive (DX3-?6) xenograft model, we observed a ~2-fold enhancement in tumor uptake over Ad5-EGFPWT following systemic delivery. Furthermore, ~5-fold-fewer Ad5-EGFPA20 genomes were detected in the liver (P = 0.0002), correlating with reduced serum transaminase levels and E1A expression. Warfarin pretreatment, to deplete coagulation factors, did not improve tumor uptake significantly with either virus but did significantly reduce liver sequestration and hepatic toxicity. The ability of Ad5-EGFPA20 to improve delivery to ?v?6, combined with its reduced hepatic tropism and toxicity, highlights its potential as a prototype virus for future clinical investigation.

PDF Coughlan_et_al.,_2009.pdf - Version of Record
Restricted to Repository staff only
Download (828kB)

Citation

Coughlan, Lynda, Vallath, Sabari, Saha, Antonio, Flak, Magdalena, MacNeish, Ian A., Vassaux, Georges, Marshall, John F., Hart, Ian R. and Thomas, Gareth J. (2009) In vivo retargeting of adenovirus type 5 to ?v?6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery Journal of Virology, 83, (13), pp. 6416-6428. (doi:10.1128/JVI.00445-09).

More information

Published date: July 2009

Identifiers

Local EPrints ID: 66680
URI: http://eprints.soton.ac.uk/id/eprint/66680
ISSN: 0022-538X
PURE UUID: 536cba17-62fe-4023-a249-0d8eafae62a8

Catalogue record

Date deposited: 10 Jul 2009
Last modified: 19 Jul 2017 00:23

Export record

Altmetrics

Contributors

Author: Lynda Coughlan
Author: Sabari Vallath
Author: Antonio Saha
Author: Magdalena Flak
Author: Ian A. MacNeish
Author: Georges Vassaux
Author: John F. Marshall
Author: Ian R. Hart

University divisions


Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×